MX2023001410A - Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. - Google Patents

Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.

Info

Publication number
MX2023001410A
MX2023001410A MX2023001410A MX2023001410A MX2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A
Authority
MX
Mexico
Prior art keywords
intra
pharmaceutical composition
articular corticosteroid
pain control
corticosteroid
Prior art date
Application number
MX2023001410A
Other languages
English (en)
Spanish (es)
Inventor
Sheue- Fang SHIH
Carl Oscar Brown
Original Assignee
Tlc Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals Inc filed Critical Tlc Biopharmaceuticals Inc
Publication of MX2023001410A publication Critical patent/MX2023001410A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2023001410A 2020-08-05 2021-08-05 Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. MX2023001410A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05
PCT/US2021/044619 WO2022031898A1 (en) 2020-08-05 2021-08-05 Pharmaceutical composition of intra-articular corticosteroid for pain control

Publications (1)

Publication Number Publication Date
MX2023001410A true MX2023001410A (es) 2023-03-06

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023001410A MX2023001410A (es) 2020-08-05 2021-08-05 Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.

Country Status (13)

Country Link
US (1) US12514820B2 (https=)
EP (1) EP4192426A1 (https=)
JP (1) JP2023537474A (https=)
KR (1) KR20230048066A (https=)
CN (1) CN116348093A (https=)
AU (1) AU2021320774A1 (https=)
BR (1) BR112023001926A2 (https=)
CA (1) CA3187955A1 (https=)
CL (1) CL2023000315A1 (https=)
IL (1) IL300354A (https=)
MX (1) MX2023001410A (https=)
TW (1) TW202220668A (https=)
WO (1) WO2022031898A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2854769T1 (sl) * 2012-07-05 2023-09-29 Taiwan Liposome Company, Ltd. Postopki za zdravljenje artritisa
ES2985871T3 (es) * 2017-03-14 2024-11-07 Seikagaku Kogyo Co Ltd Composición para tratar artropatías y kit que incluye la misma
EP3849522A1 (en) * 2018-09-16 2021-07-21 TLC Biopharmaceuticals, Inc. Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

Also Published As

Publication number Publication date
EP4192426A1 (en) 2023-06-14
TW202220668A (zh) 2022-06-01
KR20230048066A (ko) 2023-04-10
IL300354A (en) 2023-04-01
US20230285293A1 (en) 2023-09-14
JP2023537474A (ja) 2023-09-01
CN116348093A (zh) 2023-06-27
US12514820B2 (en) 2026-01-06
AU2021320774A1 (en) 2023-03-09
WO2022031898A1 (en) 2022-02-10
CA3187955A1 (en) 2022-02-10
CL2023000315A1 (es) 2023-09-22
BR112023001926A2 (pt) 2023-03-07

Similar Documents

Publication Publication Date Title
MX2022005994A (es) Uso del inhibidor de fak en la preparacion de un farmaco para el tratamiento contra tumores con mutacion nras.
ZA202202361B (en) Treatment of hidradenitis suppurativa using jak inhibitors
PH12021551792A1 (en) Bi-ligand drug conjugate and use thereof
PH12012501741A1 (en) Treatment of lupus arthritis using laquinimod
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
MX2017006938A (es) Terapia de combinacion para el tratamiento de cancer.
MX2024011142A (es) Tratamiento de neurofibromas cutaneos con mirdametinib.
ZA202006072B (en) Ret inhibitor for use in treating cancer having a ret alteration
MX2022007911A (es) Procedimiento de tratamiento de una infeccion virica usando un agonista de tlr7.
WO2014160155A3 (en) Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof
MX2020010034A (es) Metodo de tratamiento de enfermedad fibrotica.
BR112022025920A2 (pt) Tratamento de artrite reumatoide
BR112022024999A2 (pt) Inibidor tlr7 em combinação com prednisolona ou hidroxicloroquina para o tratamento do lúpus eritematoso cutâneo
EP1677806A4 (en) METHOD FOR THE TREATMENT OF ACUTE AND HYALURONIC ACIDIFICATION CAUSED BY EXCESSIVE INJURY AND STUPIDATION
MX2023001410A (es) Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
MX2021002590A (es) Metodos de uso de un compuesto de fenoxipropilamina para tratar el dolor.
BR112021024835A2 (pt) Tratamento para sinuclenopatias
BR112022005765A2 (pt) Tratamento contra afecções espondiloartríticas e psoriáticas com upadacitinib
MX2018005876A (es) Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas.
Mlachkova et al. Effectiveness of NSAIDs for pain management in periodontal surgery
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
ZA202100604B (en) Methods to reduce complications of intra-articular steroid
PH12022553441A1 (en) Compositions and methods for treating obsessive-compulsive disorder
BR112023023702A2 (pt) Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga